Harvard Business Review

MARCH 28, 2012

billion to acquire the webOS operating system, Hewlett-Packard discontinued its webOS-based series of smartphones and line of Touchpad tablets — losing its bet on a webOS-everywhere future. This means they're buying drugs that could be similar to others already on or coming soon to the market.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Think of it as a 360-degree/24-7 support system. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 8, 2013

government is often portrayed as providing a safeguard against market failure. Elsewhere, I have called this role, which entails creating and shaping markets more than "fixing" them, " the entrepreneurial state.". An even bigger question for the American taxpayer is whether such support leads to a "parasitic" innovation eco-system.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. America's higher education system is a magnet for talented leaders from all over the world.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

JUNE 3, 2013

Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., Where was its leadership bench?

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Everything, everyone, and every system evolves over time. Use Convergence Thinking. What two or more areas are merging? Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. It is commonly believed that emerging market companies tap Western R&D talent in order to 'move up the value chain.'

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

FEBRUARY 16, 2016

If their projections turn out to be right, we should get ready for a bumpy road ahead, with market volatility and negative surprises. The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g.,

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

JULY 16, 2013

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

NOVEMBER 29, 2016

It will increasingly help government health agencies, payers, and providers to make decisions about such issues as drug discovery, patient access, and marketing.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 17, 2014

An estimated 250 funds are actively raising capital in a market that the Global Impact Investing Network estimates at $25 billion. In impact investing, we need to find a way to place that same premium on social impact by valuing the public good being created – just like we do in early stage R&D in science, IT, health, and biotechnology.

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

SEPTEMBER 11, 2014

That means new technologies and new competitors are hitting the market at an unprecedented rate. When Intuitive Surgical launched the Da Vinci System medical robot — which allows surgeons to operate using 3-D visualization and four robotic arms — the company faced significant technical as well as demand uncertainty.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

The West defeated the Soviet Union not through warfare but by maintaining a superior economic system with higher technological standards. trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials.

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

MAY 15, 2015

Mary Shelley told us nothing about the future of biotechnology, but the popularity and plausibility of Frankenstein: The Modern Prometheus tells us a lot about 1818’s fears and aspirations for technology and its relation to society. Taken as a whole, science fiction’s predictions do not outperform random chance.

Class 8

Class Open-book Politics Biotechnology 8

Harvard Business Review

NOVEMBER 9, 2016

While it’s understandable that stock and currency markets would react this way to the outcome of the election, I believe that it’s somewhat of an overreaction. The price of steel is set in international markets and is subject to high cyclical variations. president. Source ideas through foreign direct investment.

Cooper 14

Cooper Long-term Industry Health Care 14